[1] |
World Health Organization. Global tuberculosis report 2019[R]. Geneva, Switzerland:World Health Organization, 2019.
|
[2] |
SHI L B, JIANG Q K, BUSHKIN Y, et al. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection[J]. mBio, 2019, 10(2):e02550-18.
|
[3] |
HMAMA Z, PEÑA-DÍAZ S, JOSEPH S, et al. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis[J]. Immunol Rev, 2015, 264(1):220-232.
|
[4] |
PAIK S, KIM J K, CHUNG C, et al. Autophagy:a new strategy for host-directed therapy of tuberculosis[J]. Virulence, 2019, 10(1):448-459.
|
[5] |
PADHI A, PATTNAIK K, BISWAS M, et al. Mycobacterium tuberculosis LprE suppresses TLR2-dependent cathelicidin and autophagy expression to enhance bacterial survival in macrophages[J]. J Immunol, 2019, 203(10):2665-2678.
|
[6] |
LEE H J, KO H J, SONG D K, et al. Lysophosphatidylcholine promotes phagosome maturation and regulates inflammatory mediator production through the protein kinase a-phosphatidylinositol 3 kinase-p38 mitogen-activated protein kinase signaling pathway during Mycobacterium tuberculosis infection in mouse macrophages[J]. Front Immunol, 2018, 9:920.
|
[7] |
CUMMING B M, ADDICOTT K W, ADAMSON J H, et al. Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages[J]. eLife, 2018, 7:e39169.
|
[8] |
AHLUWALIA P K, PANDEY R K, SEHAJPAL P K, et al. Perturbed microRNA expression by Mycobacterium tuberculosis promotes macrophage polarization leading to pro-survival foam cell[J]. Front Immunol, 2017, 8:107.
|
[9] |
SINGH R, KAUSHIK S, WANG Y J, et al. Autophagy regulates lipid metabolism[J]. Nature, 2009, 458(7242):1131-1135.
|
[10] |
KE R, XU Q C, LI C, et al. Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism[J]. Cell Biol Int, 2018, 42(4):384-392.
|
[11] |
MEI S, NI H M, MANLEY S, et al. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes[J]. J Pharmacol Exp Ther, 2011, 339(2):487-498.
|
[12] |
FURUHASHI M, SAITOH S, SHIMAMOTO K, et al. Fatty acid-binding protein 4 (FABP4):pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases[J]. Clin Med Insights Cardiol, 2014, 8(S3):23-33.
|
[13] |
GUAITA-ESTERUELAS S, BOSQUET A, SAAVEDRA P, et al. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins[J]. Mol Carcinogen, 2017, 56(1):208-217.
|
[14] |
BOß M, KEMMERER M, BRÜNE B, et al. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages[J]. Atherosclerosis, 2015, 240(2):424-430.
|
[15] |
DENG T M, WANG Y H, WANG C C, et al. FABP4 silencing ameliorates hypoxia reoxygenation injury through the attenuation of endoplasmic reticulum stress-mediated apoptosis by activating PI3K/Akt pathway[J]. Life Sci, 2019, 224:149-156.
|
[16] |
ZHANG Q W, SUN J X, WANG Y L, et al. Antimycobacterial and anti-inflammatory mechanisms of baicalin via induced autophagy in macrophages infected with Mycobacterium tuberculosis[J]. Front Microbiol, 2017, 8:2142.
|
[17] |
WU X L, ZHANG J M, MA C J, et al. A role for Wnt/β-catenin signalling in suppressing bacillus calmette-guerin-induced macrophage autophagy[J]. Microb Pathog, 2019, 127:277-287.
|
[18] |
马沁梅, 韩璐, 邓光存, 等. 自噬在结核分枝杆菌感染中作用的研究进展[J]. 中国细胞生物学学报, 2019, 41(9):1797-1804.MA Q M, HAN L, DENG G C, et al. The research progress of autophagy in Mycobacterium tuberculosis infection[J]. Chinese Journal of Cell Biology, 2019, 41(9):1797-1804. (in Chinese)
|
[19] |
PAHARI S, NEGI S, AQDAS M, et al. Induction of autophagy through CLEC4E in combination with TLR4:an innovative strategy to restrict the survival of Mycobacterium tuberculosis[J]. Autophagy, 2020, 16(6):1021-1043.
|
[20] |
KIM J K, LEE H M, PARK K S, et al. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2[J]. Autophagy, 2017, 13(2):423-441.
|
[21] |
KIM M J, WAINWRIGHT H C, LOCKETZ M, et al. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism[J]. Embo Mol Med, 2010, 2(7):258-274.
|
[22] |
REMMERIE A, SCOTT C L. Macrophages and lipid metabolism[J]. Cell Immunol, 2018, 330:27-42.
|
[23] |
LEE W, VANDERVEN B C, FAHEY R J, et al. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress[J]. J Biol Chem, 2013, 288(10):6788-6800.
|
[24] |
HOTAMISLIGIL G S, BERNLOHR D A. Metabolic functions of FABPs-mechanisms and therapeutic implications[J]. Nat Rev Endocrinol, 2015, 11(10):592-605.
|
[25] |
HARJES U, BRIDGES E, GHARPURE K M, et al. Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4[J]. Oncogene, 2017, 36(7):912-921.
|
[26] |
HERAS-SANDOVAL D, PÉREZ-ROJAS J M, HERNÁNDEZ-DAMIÁN J, et al. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration[J]. Cell Signal, 2014, 26(12):2694-2701.
|
[27] |
KHAWAR M B, GAO H, LI W. Autophagy and lipid metabolism[M]//QIN Z H. Autophagy:Biology and Diseases. Singapore:Springer, 2019:359-374.
|
[28] |
DUAN W J, LI Y F, LIU F L, et al. A SIRT3/AMPK/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 264.7 macrophages[J]. Free Radical Biol Med, 2016, 95:230-242.
|
[29] |
LIN S C, HARDIE C. AMPK:sensing glucose as well as cellular energy status[J]. Cell Metab, 2018, 27(2):299-313.
|
[30] |
EGAN D, KIM J, SHAW R J, et al. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR[J]. Autophagy, 2011, 7(6):643-644.
|
[31] |
ZACHARI M, GANLEY I G. The mammalian ULK1 complex and autophagy initiation[J]. Essays Biochem, 2017, 61(6):585-596.
|
[32] |
LI W, ZHANG L L. Regulation of ATG and autophagy initiation[M]//QIN Z H. Autophagy:Biology and Diseases. Singapore:Springer, 2019:41-65.
|